To report a case of significantly elevated CA19-9 in a patient with ovarian endometriosis, highlighting the rarity of this occurrence in benign conditions and providing clinical evidence for the differential diagnosis of benign and malignant ovarian lesions.
Approach:
Case Presentation: A 44-year-old female with a history of ovarian cysts presented with elevated CA19-9 levels (up to 2453.1 U/mL) and pelvic symptoms, including left lower abdominal pain and weight loss. Extensive workup, including gastroenterological endoscopy and abdominal MRI, excluded gastrointestinal malignancies, and laparoscopy confirmed ovarian endometriosis.
Key Findings:
CA19-9 level was significantly elevated at 2453.1 U/mL in a case of ovarian endometriosis.
The patient had a long-standing history of ovarian cysts and presented with abdominal pain and weight loss.
Postoperative follow-up showed normalization of CA19-9 levels with no lesion recurrence.
Interpretation:
Elevated CA19-9 levels in benign conditions like ovarian endometriosis can complicate diagnosis.
Limitations:
The case report is based on a single patient, limiting generalizability.
The exact pathophysiological mechanism for elevated CA19-9 in ovarian endometriosis remains unclear.
Conclusion:
Elevated CA19-9 in female patients with ovarian cysts and pelvic symptoms warrants careful evaluation to differentiate between benign and malignant conditions.
